Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
05/31/2012 | WO2012071145A1 Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders |
05/31/2012 | WO2012071135A2 Methods for removing pathogens from a platelet preparation |
05/31/2012 | WO2012071131A1 Methods and compositions to detect a biological activity |
05/31/2012 | WO2012071097A1 Methods for diagnosing and treating neuroendocrine cancer |
05/31/2012 | WO2012071096A2 Arid1a and ppp2r1a mutations in cancer |
05/31/2012 | WO2012070863A2 Method for detecting nucleic acids using a nucleic acid enzyme/molecular beacon |
05/31/2012 | WO2012070861A2 Stomach cancer-specific methylation biomarker for stomach cancer diagnosis |
05/31/2012 | WO2012070809A2 Apparatus, system and method for detecting target nucleic acids |
05/31/2012 | WO2012070788A2 Method and kit for the quantification of nucleic acids |
05/31/2012 | WO2012070776A2 Method for analyzing and predicting risk of hepatocellular carcinoma in patients with chronic hepatitis b |
05/31/2012 | WO2012070730A1 Method for detecting alk gene rearrangement and method for diagnosing cancer using the same |
05/31/2012 | WO2012070618A1 Amplified nucleic acid detection method and detection device |
05/31/2012 | WO2012070617A1 Phosphatidylserine quantification method and quantification kit |
05/31/2012 | WO2012070510A1 Method for testing risk of cardiac infarction |
05/31/2012 | WO2012070056A2 Method and system for prognosis and treatment of diseases using portfolio of genes |
05/31/2012 | WO2012070041A1 Methods and kits for differential staining of abnormal urinary system cells |
05/31/2012 | WO2012070037A2 Methods and materials for classification of tissue of origin of tumor samples |
05/31/2012 | WO2012070014A2 Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells |
05/31/2012 | WO2012069941A2 Vaginal indicator to detect biomarkers of good health |
05/31/2012 | WO2012069847A1 Method of diagnosing down's syndrome |
05/31/2012 | WO2012069768A1 Method for identifying a fungus, in particular a filamentous fungus, and uses |
05/31/2012 | WO2012069752A1 Device for detecting a fungal contamination |
05/31/2012 | WO2012069659A2 Multimarker panel |
05/31/2012 | WO2012069613A1 Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome |
05/31/2012 | WO2012069569A1 Thin films of mesoporous silicas as sensitive materials in gravimetric sensors for detecting or assaying vapours of nitrogen-containing compounds |
05/31/2012 | WO2012069511A1 Methods for detecting low grade inflammation |
05/31/2012 | WO2012069484A2 Method for qualitatively and quantitatively detecting specific nucleic acid sequences in real time |
05/31/2012 | WO2012069432A1 Use of kinesin inhibitors in hiv infection treatment and a method for screening them |
05/31/2012 | WO2012069139A1 Analysis of direct factor xa inhibitors |
05/31/2012 | WO2012068956A1 Detection kit for bacterial pathogens in urine samples and detection method thereof |
05/31/2012 | WO2012068955A1 Mhc region nucleic acid library, construction method therfor, and use thereof |
05/31/2012 | WO2012068949A1 Classification method based on the metagenome 16s high variable region v6 |
05/31/2012 | WO2012068919A1 Dna library and preparation method thereof, and method and device for detecting snps |
05/31/2012 | WO2012068772A1 Pcr identification method for germplasm materials of upland cotton hb red flower |
05/31/2012 | WO2012068709A1 Kit of dot immunogold orientated filtration assay and use thereof |
05/31/2012 | WO2012068701A2 Hla genotype-snp linkage database, its constructing method, and hla typing method |
05/31/2012 | WO2012068642A1 Diagnostic and/or screening agents and uses therefor |
05/31/2012 | WO2012047968A3 Mutant smoothened and methods of using the same |
05/31/2012 | WO2012047631A3 Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease |
05/31/2012 | WO2012047109A3 Mirna and mirna inhibitors that modulate adenovirus replication and/or adenovirus induced cell death |
05/31/2012 | WO2012044353A9 Hiv-1 igg3 response in acute hiv-1 |
05/31/2012 | WO2012041332A3 Genetic variations in the interleukin-6 receptor gene as predictors of the response to treatment |
05/31/2012 | WO2012040571A3 Method and apparatus for fragmenting nucleic acids |
05/31/2012 | WO2012038049A3 Amplification of distant nucleic acid targets using engineered primers |
05/31/2012 | WO2012031128A3 Microorganism imprinted polymers with integrated emission sites, and methods of making and using same |
05/31/2012 | WO2012030856A3 Compositions, methods and reaction mixtures for the detection of xenotropic murine leukemia virus-related virus |
05/31/2012 | WO2012030196A3 Oligonucleotide marker and method for identifying the same |
05/31/2012 | WO2012027503A3 Method of measuring adaptive immunity |
05/31/2012 | WO2012027446A3 Nucleic acid sequence analysis |
05/31/2012 | WO2012024658A3 Integrated analysis system |
05/31/2012 | WO2012024189A3 Compositions and methods for determining predisposition to developing metabolic syndrome |
05/31/2012 | WO2012020679A8 Method and test piece for simultaneously typing influenza virus a and detecting oseltamivir phosphate-resistant mutation |
05/31/2012 | WO2012018609A3 Mig6 and therapeutic efficacy |
05/31/2012 | WO2012009711A3 Retrovirus detection |
05/31/2012 | WO2011163497A3 Method for determining predisposition to esophageal-related disorders |
05/31/2012 | WO2011160048A3 Methods of identifying therapeutic agents for treating persister and bacterial infection |
05/31/2012 | WO2011153234A3 Methods of inhibiting alu rna and therapeutic uses thereof |
05/31/2012 | WO2011153224A3 Diagnostic methods and compositions for treatment of cancer |
05/31/2012 | WO2011149272A3 Qualitative and quantitative analytical method for analyzing the activity type of an enzyme that is activated by proteolysis |
05/31/2012 | WO2011146629A3 Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
05/31/2012 | WO2011146143A3 Enzymatic activity of psa as diagnostic marker for prostate cancer |
05/31/2012 | WO2011146120A3 Assay for identifying antigens that activate b cell receptors comprising neutralizing antibodies |
05/31/2012 | WO2011142646A3 Method for detecting hpv (human papilloma virus) and genotype thereof |
05/31/2012 | WO2011130265A3 Kras primers and probes |
05/31/2012 | WO2011107481A3 Method of diagnostic of inflammatory bowel diseases |
05/31/2012 | WO2011049312A9 High throughput oligonucleotide synthesizer |
05/31/2012 | WO2011002856A3 Method for neutralization of antibiotics in a culture medium |
05/31/2012 | US20120137388 Cucumber Vein Yellowing Virus (CVYV) Resistant Cucumber Plants (Cucumis Sativus L.) |
05/31/2012 | US20120137385 Transcription factors |
05/31/2012 | US20120137381 Tomato hybrid ps 01565172 |
05/31/2012 | US20120136141 Integrin Heterodimer And A Subunit Thereof |
05/31/2012 | US20120136064 Methods for screening to identify therapeutic agents for alzheimer's disease and use thereof |
05/31/2012 | US20120136045 Screening for compounds that modulate gpr3-mediated beta-arrestin signaling and amyloid beta peptide generation |
05/31/2012 | US20120136040 Hybrid interfering rna |
05/31/2012 | US20120136034 Fatty acids as anti-inflammatory agents |
05/31/2012 | US20120136007 Methods and compositions for treating degenerative and ischemic disorders |
05/31/2012 | US20120135983 DNA Damage Repair Inhibitors for the Treatment of Cancer |
05/31/2012 | US20120135950 Antiviral treatment of lymphoma and cancer |
05/31/2012 | US20120135892 siRNA targeting spleen tyrosine kinase |
05/31/2012 | US20120135891 Methods and devices for early detection of cancer cells and types through micromechanical interactions |
05/31/2012 | US20120135888 Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy |
05/31/2012 | US20120135886 Method for detection of, or the risk of, bladder cancer |
05/31/2012 | US20120135884 Compositions and methods for diagnosing and treating macular degeneration |
05/31/2012 | US20120135882 Methods for diagnosing chronic kidney disease and assessing the risk of disease progression |
05/31/2012 | US20120135881 Markers for detection of gastric cancer |
05/31/2012 | US20120135878 Generation of Neural Stem Cells from Human Trophoblast Stem Cells |
05/31/2012 | US20120135877 DNA Methylation Markers For Prostate Cancer Field Defect |
05/31/2012 | US20120135873 Genome determination assay |
05/31/2012 | US20120135871 High throughput detection of molecular markers based on aflp and high through-put sequencing |
05/31/2012 | US20120135530 Detection of target analytes using particles and electrodes |
05/31/2012 | US20120135516 Artificial antibody polypeptides |
05/31/2012 | US20120135501 Recombinant poxvirus expressing homologous genes inserted |
05/31/2012 | US20120135497 Differentially fluorescent yeast biosensors for the detection and biodegradation of chemical agents |
05/31/2012 | US20120135496 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof |
05/31/2012 | US20120135456 Method and kit for detection of guaiacol-producing bacterium |
05/31/2012 | US20120135455 Smart Packaging For Detecting Microorganisms |
05/31/2012 | US20120135454 Methods for separation, characterization and/or identification of microorganisms using spectroscopy |
05/31/2012 | US20120135453 Methods of Treatment Using CCA1 Inhibitors |
05/31/2012 | US20120135452 Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof |
05/31/2012 | US20120135451 Method and Apparatus for Evaluation of Toxicity |